[Infographics] Remdesivir reduces mortality in elderly hospitalized for COVID-19 in the real world, regardless of age group or supplemental oxygen needs

09 Aug 2024
[Infographics] Remdesivir reduces mortality in elderly hospitalized for COVID-19 in the real world, regardless of age group o
Remdesivir is associated with reduced mortality among elderly patients hospitalized for COVID-19, regardless of supplemental oxygen requirements upon admission and age groups, a real-world study presented in ESCMID Global 2024 has shown.
This special report is supported by an education grant from the industry. 

Related MIMS Drugs

Resources

[Infographics] Remdesivir reduces mortality in elderly hospitalized for COVID-19 in the real world, regardless of age group o

[Infographics] Remdesivir reduces mortality in elderly hospitalized for COVID-19 in the real world, regardless of age group or supplemental oxygen needs

[Infographics] Remdesivir reduces mortality in elderly hospitalized for COVID-19 in the real world, regardless of age group o

[Infographics] Remdesivir reduces mortality in elderly hospitalized for COVID-19 in the real world, regardless of age group or supplemental oxygen needs